Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00119054 · ClinicalTrials.gov registry record · NA

Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes

A NA study of Hypertension and Diabetes Mellitus, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
302
Enrollment target
1
Study location

NCT00119054: Completed NA study of Hypertension and Diabetes Mellitus, sponsored by US Department of Veterans Affairs.

NCT00119054 is a NA study of Hypertension and Diabetes Mellitus that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 302 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00119054, a NA study of Hypertension and Diabetes Mellitus, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
302 participants
Enrollment target
1
Study location

Study Summary

Patients treated at Veterans Affairs (VA) medical centers are older and have multiple chronic conditions. Two of the most common conditions in the VA population are hypertension (HTN) and Type 2 diabetes (DM). Unfortunately, DM and HTN have few perceptible symptoms on a daily basis that motivate patients to comply with treatment recommendations and lifestyle changes. Thus, serious complications and long-term adverse outcomes are common in both of these conditions. Home telehealth is a general term used to describe the delivery of health care services to the patient's home using audio, video, or other telecommunications technologies. Although home telehealth offers a number of theoretical advantages, few well-designed controlled clinical trials have been conducted to establish efficacy and cost benefit. Furthermore, projects to date have focused on special populations, e.g., heart failure or mental illnesses. Since home telehealth may hold the most promise for individuals dealing with multiple chronic illnesses, there is a need for population-based studies addressing the needs of patients in primary care settings. Care coordination, as defined by the VHA Office of Care Coordination, is a process of assessment and ongoing monitoring of patients using home telehealth to proactively enable prevention, investigation, and treatment that enhances the health of patients and prevents unnecessary and inappropriate use of resources. Care coordination embeds technology into a care management process. This results in the right care, at the right time, in the right place.

Interventions

  • BEHAVIORAL In Home Health Messaging Device

Study Locations (1)

Iowa

  • Iowa City VA Health Care System, Iowa City, IA - Iowa City

Trial Details

FieldValue
Enrollment Target 302 participants
Start Date 2005-09
Est. Completion 2007-12
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00119054 record still lists

NCT00119054 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which In Home Health Messaging Device is the first listed.

NCT00119054 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT00119054 about?

NCT00119054 is a clinical study titled "Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes". Patients treated at Veterans Affairs (VA) medical centers are older and have multiple chronic conditions. Two of the most common conditions in the VA population are hypertension (HTN) and Type 2 diabetes (DM). Unfortunately, DM and HTN have few perceptible symptoms on a daily basis that motivate pat...

What is the current status of trial NCT00119054?

This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2005-09. Estimated completion is 2007-12.

What conditions does trial NCT00119054 study?

This clinical trial studies the following conditions: Hypertension, Diabetes Mellitus.

What interventions are being tested in trial NCT00119054?

The interventions under investigation include: In Home Health Messaging Device (BEHAVIORAL).

Who is sponsoring clinical trial NCT00119054?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00119054 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00119054's enrollment target sits among peer trials

302 167th of 470 higher than 302 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05722561 · 302 participants · Phase 2

    E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

  • NCT06015737 · 302 participants · Phase 3

    A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

  • NCT07176273 · 302 participants · NA

    Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)

  • NCT05508971 · 303 participants · NA

    Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00119054, the US trial registry maintained by the National Library of Medicine. NCT00119054 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.